Security key
68622P109
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC)
CUSIP: 68622P109
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 35,685,685
- Total 13F value
- $874,284,848
- Share change
- +3,077,832
- SEC-reported price per share
- $24.50
- Number of holders
- 82
- Value change
- +$71,774,159
- Number of buys
- 49
- Number of sells
- 20
- Shares outstanding
- 105,956,500
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
82
Top holders
10
ORIC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Oric Pharmaceuticals, Inc. SEC filings
Oric Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68622P109
Recent filing periods:
Ownership snapshot
Top reported holders of ORIC - Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F
Lead comparable stake: 5.1%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 5.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
5.1%
Column Group LLC
4.5%
EcoR1 Capital, LLC
2.9%
ORBIMED ADVISORS LLC
2.8%
BlackRock Finance, Inc.
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
5.1%
|
$184,562,000
5,452,347 shares
|
— | 31 Dec 2020 |
| Column Group LLC |
13F
Company
|
4.5%
|
$161,403,000
4,768,181 shares
|
— | 31 Dec 2020 |
| EcoR1 Capital, LLC |
13F
Company
|
2.9%
|
$104,672,000
3,092,218 shares
|
— | 31 Dec 2020 |
| ORBIMED ADVISORS LLC |
13F
Company
|
2.8%
|
$98,909,000
2,921,967 shares
|
— | 31 Dec 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
1.8%
|
$63,602,000
1,878,908 shares
|
— | 31 Dec 2020 |
| Euclidean Capital LLC |
13F
Company
|
1.3%
|
$47,405,000
1,400,435 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
82
Shares
35,685,685
Rows available
82
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q1 2021 Across Filers
Q1 2021 holders
82
Q1 2021 holders
82
Holder diff
0
| Investor | Q1 2021 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend